These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33782000)

  • 21. Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections.
    Luque S; Escaño C; Sorli L; Li J; Campillo N; Horcajada JP; Salas E; Grau S
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients.
    Garonzik SM; Li J; Thamlikitkul V; Paterson DL; Shoham S; Jacob J; Silveira FP; Forrest A; Nation RL
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3284-94. PubMed ID: 21555763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Greater optimisation of pharmacokinetic/pharmacodynamic parameters through a loading dose of intravenous colistin in paediatric patients.
    Wacharachaisurapol N; Phasomsap C; Sukkummee W; Phaisal W; Chanakul A; Wittayalertpanya S; Chariyavilaskul P; Puthanakit T
    Int J Antimicrob Agents; 2020 Jun; 55(6):105940. PubMed ID: 32179149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?
    Nation RL; Garonzik SM; Li J; Thamlikitkul V; Giamarellos-Bourboulis EJ; Paterson DL; Turnidge JD; Forrest A; Silveira FP
    Clin Infect Dis; 2016 Mar; 62(5):552-558. PubMed ID: 26607424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population Pharmacokinetics of Colistin Sulfate in Critically Ill Patients: Exposure and Clinical Efficacy.
    Yu XB; Zhang XS; Wang YX; Wang YZ; Zhou HM; Xu FM; Yu JH; Zhang LW; Dai Y; Zhou ZY; Zhang CH; Lin GY; Pan JY
    Front Pharmacol; 2022; 13():915958. PubMed ID: 35784679
    [No Abstract]   [Full Text] [Related]  

  • 26. Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria.
    Kristoffersson AN; Rognås V; Brill MJE; Dishon-Benattar Y; Durante-Mangoni E; Daitch V; Skiada A; Lellouche J; Nutman A; Kotsaki A; Andini R; Eliakim-Raz N; Bitterman R; Antoniadou A; Karlsson MO; Theuretzbacher U; Leibovici L; Daikos GL; Mouton JW; Carmeli Y; Paul M; Friberg LE
    Clin Microbiol Infect; 2020 Dec; 26(12):1644-1650. PubMed ID: 32213316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous colistimethate (colistin) use in critically ill children without cystic fibrosis.
    Falagas ME; Sideri G; Vouloumanou EK; Papadatos JH; Kafetzis DA
    Pediatr Infect Dis J; 2009 Feb; 28(2):123-7. PubMed ID: 19116601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Challenge for higher colistin dosage in critically ill patients receiving continuous venovenous haemodiafiltration.
    Karaiskos I; Friberg LE; Galani L; Ioannidis K; Katsouda E; Athanassa Z; Paskalis H; Giamarellou H
    Int J Antimicrob Agents; 2016 Sep; 48(3):337-41. PubMed ID: 27474468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of a loading dose of colistin methanesulfonate in critically ill patients: population pharmacokinetics, protein binding, and prediction of bacterial kill.
    Mohamed AF; Karaiskos I; Plachouras D; Karvanen M; Pontikis K; Jansson B; Papadomichelakis E; Antoniadou A; Giamarellou H; Armaganidis A; Cars O; Friberg LE
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4241-9. PubMed ID: 22615285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcomes of colistin methanesulfonate sodium in correlation with pharmacokinetic parameters in critically ill patients with multi-drug resistant bacteria-mediated infection: A systematic review and meta-analysis.
    Son JY; Kim S; Porsuk T; Shin S; Choi YJ
    J Infect Public Health; 2024 May; 17(5):843-853. PubMed ID: 38554590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Predictive Equation for the Estimation of Plasma Concentrations of Formed Colistin in Patients Treated with Colistimethate Sodium for Multidrug-Resistant Gram-Negative Bacterial Infections.
    Luque S; Sorlí L; Li J; Fernández-Sala X; Berenguer N; Colominas-González E; Benítez-Cano A; Montero MM; Subirana I; Prim N; García-Paricio R; Horcajada JP; Grau S
    Ther Drug Monit; 2024 Jul; ():. PubMed ID: 38984536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substantial Targeting Advantage Achieved by Pulmonary Administration of Colistin Methanesulfonate in a Large-Animal Model.
    Landersdorfer CB; Nguyen TH; Lieu LT; Nguyen G; Bischof RJ; Meeusen EN; Li J; Nation RL; McIntosh MP
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Model-Informed Rationale for Early Therapeutic Drug Monitoring of Colistin in Critically Ill Patients.
    Mathew SK; Rao SV; Prabha R; Neely MN; Mathew BS; Aruldhas BW; Veeraraghavan B; Kandasamy S
    J Clin Pharmacol; 2023 Jan; 63(1):57-65. PubMed ID: 35924629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in Colistin Administration and Bacterial and Treatment Outcomes in Critically Ill Patients.
    Jung S; Chung EK; Jun MS; Son ES; Rhie SJ
    Sci Rep; 2019 Jun; 9(1):8781. PubMed ID: 31217523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration of colistin methanesulfonate.
    Imberti R; Cusato M; Accetta G; Marinò V; Procaccio F; Del Gaudio A; Iotti GA; Regazzi M
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4416-21. PubMed ID: 22687507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Shedding light on the use of colistin: still gaps to be filled].
    Luque S; Grau S; Berenguer N; Horcajada JP; Sorlí L; Montero MM; Salas E
    Enferm Infecc Microbiol Clin; 2011 Apr; 29(4):287-96. PubMed ID: 21440335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes of colistin pharmacokinetics in critically ill patients due to the extracorporeal membrane oxygenation: protocol for the COL-ECMO2022 trial - a prospective, non-randomised, open-label phase IV pharmacokinetic clinical trial.
    Suk P; Rychlíčková J; Součková L; Kubíčková V; Urbánek K
    BMJ Open; 2023 Jul; 13(7):e071649. PubMed ID: 37518089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous colistin for multidrug-resistant gram-negative infections in critically ill pediatric patients.
    Kapoor K; Jajoo M; Dublish S; Dabas V; Gupta S; Manchanda V
    Pediatr Crit Care Med; 2013 Jul; 14(6):e268-72. PubMed ID: 23689704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosing of colistin-back to basic PK/PD.
    Bergen PJ; Li J; Nation RL
    Curr Opin Pharmacol; 2011 Oct; 11(5):464-9. PubMed ID: 21835694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of Aerosolized Colistin in a Mouse Lung Infection Model.
    Lin YW; Zhou QT; Han ML; Onufrak NJ; Chen K; Wang J; Forrest A; Chan HK; Li J
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.